Page last updated: 2024-09-03

1,25-dihydroxyergocalciferol and Breast Neoplasms

1,25-dihydroxyergocalciferol has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ChodyƄski, M; Kutner, A; Marcinkowska, E; Opolski, A; Szelejewski, W; Wietrzyk, J1
Horst, RL; Ramberg, CF; Reinhardt, TA1

Other Studies

2 other study(ies) available for 1,25-dihydroxyergocalciferol and Breast Neoplasms

ArticleYear
Synthesis and antiproliferative activity of side-chain unsaturated and homologated analogs of 1,25-dihydroxyvitamin D(2). (24E)-(1S)-24-Dehydro-24a-homo-1,25-dihydroxyergocalciferol and congeners.
    Steroids, 2002, Volume: 67, Issue:9

    Topics: Animals; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Drug Combinations; Ergocalciferols; Humans; Leukemia; Mice; Molecular Structure; Tumor Cells, Cultured

2002
Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and its 24 epimer.
    Archives of biochemistry and biophysics, 1989, Aug-15, Volume: 273, Issue:1

    Topics: Animals; Binding, Competitive; Breast Neoplasms; Calcitriol; Calcium; Cattle; Cell Line; Chickens; Ergocalciferols; Humans; Intestinal Mucosa; Kinetics; Protein Binding; Rats; Receptors, Calcitriol; Receptors, Steroid; Thymus Gland; Tumor Cells, Cultured

1989